CVS Health (CVS) Tops Q2 Expectations and Raises Guidance But Shares Fall on 2022 Commentary That is 'Not Surprising' Says Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to CVS Health (CVS) Tops Q2 Expectations and Raises Guidance But Shares Fall on 2022 Commentary That is 'Not Surprising' Says Analyst

CVS Health (CVS) PT Raised to $95 at Cantor Fitzgerald

August 4, 2021 12:48 PM EDT

Cantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $95.00 (from $92.00) while maintaining a Overweight rating following earnings.

The analyst commented, ". We reiterate our Overweight rating on CVS shares and increase our price target to $95 from $92. Before the market open on Wednesday, August... More